The Menarini Group has companies all over the world.
Menarini is the leading Italian pharmaceutical group in the world. It is present in over 100 countries, including 70 with direct presence thanks to a network of agents, and in more than 30 countries with distributors and local partners. Undisputed leader in Italy with sales concentrated mainly in Europe, the Menarini Group is among the market leaders in Eastern and Central Europe, the Baltics, Uzbekistan, Moldavia, Armenia and Azerbaijan, and it ranks third in Russia and Kazakhstan.
The Group has been present in Central America (Guatemala, Dominican Republican, Nicaragua, Honduras, Costa Rica, Panama, El Salvador) since the early '80s and ranks among the top five companies on the market. Menarini has been in Mexico since 2008, and most recently opening in Colombia and Perù.
Asia represents another of the Group's great success stories: ever since its first joint venture in India in 1995, Menarini has been increasing its presence in the Asian market. In 2011 it acquired the Invida Group (now named Menarini Asia Pacific). Distribution spreads throughout India, China, Singapore, Australia, Hong Kong, Indonesia, Malaysia, New Zealand, South Korea, Taiwan, Thailand, the Philippines, Vietnam, Pakistan and Macao.
The Group is present in Central and South African markets, as well as that of the North African countries (Morocco, Tunisia, Algeria, Libya, Egypt) and French-speaking Africa. Menarini also holds an important position in the Middle East, especially in Jordan, Lebanon, Syria, Saudi Arabia and the Gulf countries, where it has acquired significant market shares.